
Sign up to save your podcasts
Or


Send us Fan Mail
Discover groundbreaking insights as we chat with Dr. Jason Lowe about innovative research on equine joint health, recently spotlighted in JAVMA. Prepare to have your perspectives shifted on the veterinary approach to joint disease, inflammation, and immune responses, as Jason unveils the results of a study on 2.5% injectable polyacrylamide hydrogel. The study findings reveal an intriguing, macrophage-driven inflammatory response that is transient and stays within normal lab ranges, resolving within 90 days. We explore how this treatment remarkably becomes one with the joint, encouraging the formation of a new synovial cell layer, and we consider the implications for equine sports medicine.
Our conversation doesn't stop at the cellular level; we also tackle the practicalities of equine joint management. Emphasizing the critical role of accurate diagnosis prior to intervention, we discuss how a deep understanding of polyacrylamide hydrogel can dramatically enhance joint function and how adopting a proactive treatment strategy can boost the performance and longevity of equine athletes.
Open access article: https://doi.org/10.2460/javma.23.10.0553
INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ?
JAVMA ® : https://avma.org/JAVMAAuthors
AJVR ® : https://avma.org/AJVRAuthors
FOLLOW US:
JAVMA ® :
Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook
Instagram: JAVMA (@avma_javma) • Instagram photos and videos
Twitter: JAVMA (@AVMAJAVMA) / Twitter
AJVR ® :
Facebook: American Journal of Veterinary Research - AJVR | Facebook
Instagram: AJVR (@ajvroa) • Instagram photos and videos
Twitter: AJVR (@AJVROA) / Twitter
JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals
By AVMA Journals4.7
1313 ratings
Send us Fan Mail
Discover groundbreaking insights as we chat with Dr. Jason Lowe about innovative research on equine joint health, recently spotlighted in JAVMA. Prepare to have your perspectives shifted on the veterinary approach to joint disease, inflammation, and immune responses, as Jason unveils the results of a study on 2.5% injectable polyacrylamide hydrogel. The study findings reveal an intriguing, macrophage-driven inflammatory response that is transient and stays within normal lab ranges, resolving within 90 days. We explore how this treatment remarkably becomes one with the joint, encouraging the formation of a new synovial cell layer, and we consider the implications for equine sports medicine.
Our conversation doesn't stop at the cellular level; we also tackle the practicalities of equine joint management. Emphasizing the critical role of accurate diagnosis prior to intervention, we discuss how a deep understanding of polyacrylamide hydrogel can dramatically enhance joint function and how adopting a proactive treatment strategy can boost the performance and longevity of equine athletes.
Open access article: https://doi.org/10.2460/javma.23.10.0553
INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ?
JAVMA ® : https://avma.org/JAVMAAuthors
AJVR ® : https://avma.org/AJVRAuthors
FOLLOW US:
JAVMA ® :
Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook
Instagram: JAVMA (@avma_javma) • Instagram photos and videos
Twitter: JAVMA (@AVMAJAVMA) / Twitter
AJVR ® :
Facebook: American Journal of Veterinary Research - AJVR | Facebook
Instagram: AJVR (@ajvroa) • Instagram photos and videos
Twitter: AJVR (@AJVROA) / Twitter
JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals

91,059 Listeners

21,927 Listeners

7,712 Listeners

400 Listeners

50 Listeners

87,563 Listeners

8,558 Listeners

14 Listeners

107 Listeners

14,453 Listeners

139 Listeners

30 Listeners

2,060 Listeners

29 Listeners

8,481 Listeners